Suppr超能文献

来自非转基因菌株ARO的含有内切多聚半乳糖醛酸酶和β-葡萄糖苷酶的食品酶的安全性评估。

Safety evaluation of the food enzyme containing endo-polygalacturonase and β-glucosidase from the non-genetically modified strain ARO.

作者信息

Zorn Holger, Barat Baviera José Manuel, Bolognesi Claudia, Catania Francesco, Gadermaier Gabriele, Greiner Ralf, Mayo Baltasar, Mortensen Alicja, Roos Yrjö Henrik, Solano Marize L M, Sramkova Monika, Van Loveren Henk, Vernis Laurence, Tokić Valentina, Criado Ana, Marini Eleonora, Cabo Laura Sanmartin, Liu Yi

出版信息

EFSA J. 2024 Dec 16;22(12):e9125. doi: 10.2903/j.efsa.2024.9125. eCollection 2024 Dec.

Abstract

The food enzyme containing endo-polygalacturonase and β-glucosidase (EC 3.2.1.15 and EC 3.2.1.21) is produced with the non-genetically modified strain ARO by DSM Food Specialties B.V. The food enzyme was free from viable cells of the production organism. It is intended to be used in five food manufacturing processes. Dietary exposure was estimated to be up to 0.609 mg total organic solids (TOS)/kg body weight per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 2217 mg TOS/kg bw per day, the highest dose tested, resulting in a margin of exposure of at least 3640. A search for the homology of the amino acid sequence of the food enzymes to known allergens was made and four matches with food allergens and 22 matches with respiratory allergens were found. Known sources of food allergens were used in the food enzyme manufacturing process. The Panel considered that the risk of allergic reactions upon dietary exposure cannot be excluded. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.

摘要

含有内切多聚半乳糖醛酸酶和β-葡萄糖苷酶(EC 3.2.1.15和EC 3.2.1.21)的食品酶由帝斯曼食品特种公司(DSM Food Specialties B.V.)使用非转基因菌株ARO生产。该食品酶不含生产生物体的活细胞。它拟用于五种食品制造工艺。据估计,欧洲人群的膳食暴露量高达每天0.609毫克总有机固体(TOS)/千克体重。遗传毒性试验未表明存在安全问题。通过对大鼠进行为期90天的重复剂量口服毒性研究来评估全身毒性。专家小组确定未观察到有害作用水平为每天2217毫克TOS/千克体重,这是测试的最高剂量,导致暴露界限至少为3640。对食品酶的氨基酸序列与已知过敏原进行了同源性搜索,发现与食物过敏原匹配4次,与呼吸道过敏原匹配22次。食品酶制造过程中使用了已知的食物过敏原来源。专家小组认为不能排除膳食暴露引起过敏反应的风险。根据提供的数据,专家小组得出结论,在预期的使用条件下,这种食品酶不会引起安全问题。

相似文献

本文引用的文献

4
Scientific Guidance for the submission of dossiers on Food Enzymes.食品酶制剂资料提交的科学指南。
EFSA J. 2021 Oct 21;19(10):e06851. doi: 10.2903/j.efsa.2021.6851. eCollection 2021 Oct.
6
Update on pollen-food allergy syndrome.花粉-食物过敏综合征更新。
Expert Rev Clin Immunol. 2020 Jun;16(6):561-578. doi: 10.1080/1744666X.2020.1774366.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验